GAMMA THERAPEUTICS, INC.

Company Information

Company Name
GAMMA THERAPEUTICS, INC.
Address
2611 SW 3RD AVE, STE 280P
PORTLAND, OR, 97201-4957
Phone
1 --
URL
n/a
DUNS
832408491
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$514,223.00
1
SBIR Phase II
$1,048,970.00
1
Chart code to be here

Award List

  1. Venous Thromboembolism Risk Marker Assay

    Amount: $514,223.00

    DESCRIPTION (provided by applicant): The application's broad, long-term objectives are to develop a rapid, high-throughput clinical assay for 3' fibrinogen that will be used to assess the risk of a pa ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Venous Thromboembolism Risk Marker Assay

    Amount: $1,048,970.00

    DESCRIPTION (provided by applicant): The application's broad, long-term objectives are to develop a rapid, high-throughput clinical assay for 3' fibrinogen that will be used to assess the ri ...

    SBIR Phase II 2011 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government